TSS
SIOX

Two Sigma Securities’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Two Sigma Securities’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,918
Closed -$7K – 2988
2022
Q1 		$7K Sell
10,918
-23,557
-68% -$20K ﹤0.01% 2057
2021
Q4 		$44K Buy
34,475
+21,414
+164% +$38K ﹤0.01% 1295
2021
Q3 		$28K Buy
+13,061
New +$28.4K ﹤0.01% 1439
2021
Q1 		– Sell
-53,148
Closed -$148K – 1922
2020
Q4 		$148K Buy
+53,148
New +$155K ﹤0.01% 1469

Other funds holding SIOX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Securities's SIOX Position: Q2 2022 in Review

Two Sigma Securities sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2022, closing a stake of 10,918 shares — an estimated $7K sold.

Two Sigma Securities first reported a position in SIOX in Q4 2020 and held it in 4 quarters. The position peaked at $148K in Q4 2020. 41 funds tracked by Wall St. Rank hold SIOX as of Q2 2022.

  • Two Sigma Securities reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Securities sold 10,918 Sio Gene Therapies Inc. Common Stock shares in Q2 2022, an estimated $7K.
  • Two Sigma Securities first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Two Sigma Securities's Sio Gene Therapies Inc. Common Stock position peaked at $148K in Q4 2020.
  • 41 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2022.

Based on Two Sigma Securities's 13F filing for Q2 2022, filed 15 Aug 2022.